Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, discusses a real-world retrospective analysis of the Vestrum Health Retina Database of patients with retinal vein occlusion.
Fekrat, of Duke University School of Medicine, said the data demonstrate that retinal vein occlusion is a chronic disease.
“Eyes with retinal vein occlusion often require treatment and anti-VEGF pharmacotherapy for many years, much longer than we initially thought,” she told Healio.